Next Article in Journal
Feasibility and Safety of Transjugular Liver Biopsy for Japanese Patients with Chronic Liver Diseases
Next Article in Special Issue
The Importance of Multimodality Imaging in the Diagnosis and Management of Patients with Infiltrative Cardiomyopathies: An Update
Previous Article in Journal
Incidental Finding of a PSMA-Positive Pancreatic Cancer in a Patient Suffering from a Metastasized PSMA-Positive Prostate Cancer
Previous Article in Special Issue
Role of CMR Mapping Techniques in Cardiac Hypertrophic Phenotype
Review

Cardiac MRI and Myocardial Injury in COVID-19: Diagnosis, Risk Stratification and Prognosis

1
Division of Cardiology, University of Illinois College of Medicine at Chicago, Chicago, IL 60612, USA
2
Department of Medicine, University of Illinois College of Medicine at Chicago, Chicago, IL 60612, USA
*
Author to whom correspondence should be addressed.
Diagnostics 2021, 11(1), 130; https://doi.org/10.3390/diagnostics11010130
Received: 25 November 2020 / Revised: 11 January 2021 / Accepted: 11 January 2021 / Published: 15 January 2021
Myocardial injury is a common complication of the COVID-19 illness and is associated with a worsened prognosis. Systemic hyperinflammation seen in the advanced stage of COVID-19 likely contributes to myocardial injury. Cardiac magnetic resonance imaging (CMR) is the preferred imaging modality for non-invasive evaluation in acute myocarditis, enabling risk stratification and prognostication. Modified scanning protocols in the pandemic setting reduce risk of exposure while providing critical data regarding cardiac tissue inflammation and fibrosis, chamber remodeling, and contractile function. The growing use of CMR in clinical practice to assess myocardial injury will improve understanding of the acute and chronic sequelae of myocardial inflammation from various pathological etiologies. View Full-Text
Keywords: COVID-19; cardiac magnetic resonance imaging (CMR); myocardial inflammation; cytokine storm COVID-19; cardiac magnetic resonance imaging (CMR); myocardial inflammation; cytokine storm
Show Figures

Figure 1

MDPI and ACS Style

Sanghvi, S.K.; Schwarzman, L.S.; Nazir, N.T. Cardiac MRI and Myocardial Injury in COVID-19: Diagnosis, Risk Stratification and Prognosis. Diagnostics 2021, 11, 130. https://doi.org/10.3390/diagnostics11010130

AMA Style

Sanghvi SK, Schwarzman LS, Nazir NT. Cardiac MRI and Myocardial Injury in COVID-19: Diagnosis, Risk Stratification and Prognosis. Diagnostics. 2021; 11(1):130. https://doi.org/10.3390/diagnostics11010130

Chicago/Turabian Style

Sanghvi, Saagar K., Logan S. Schwarzman, and Noreen T. Nazir. 2021. "Cardiac MRI and Myocardial Injury in COVID-19: Diagnosis, Risk Stratification and Prognosis" Diagnostics 11, no. 1: 130. https://doi.org/10.3390/diagnostics11010130

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop